Zai Lab Ltd. Announces Board Changes and Officer Appointments
Ticker: ZLAB · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1704292
| Field | Detail |
|---|---|
| Company | Zai Lab Ltd (ZLAB) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.000006 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, leadership, governance
TL;DR
Zai Lab's board is shaking up: Yong (Ben) Kang out, Ge Li takes over as Chairman, and two new directors join. #LeadershipChange
AI Summary
On June 11, 2024, Zai Lab Ltd. filed an 8-K report detailing the departure of Director Yong (Ben) Kang and the appointment of Dr. Ge Li as the new Chairman of the Board. The filing also announced the election of two new directors, Ms. Jian (Jane) Huang and Mr. Jonathan M. Wang, and disclosed compensatory arrangements for certain officers.
Why It Matters
This filing indicates significant shifts in Zai Lab's leadership structure, which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: medium — Changes in board composition and leadership can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Zai Lab Ltd. (company) — Registrant
- Yong (Ben) Kang (person) — Departing Director
- Dr. Ge Li (person) — Appointed Chairman of the Board
- Ms. Jian (Jane) Huang (person) — Elected Director
- Mr. Jonathan M. Wang (person) — Elected Director
- June 11, 2024 (date) — Date of Report
FAQ
Who has departed from Zai Lab Ltd.'s board of directors?
Yong (Ben) Kang has departed from Zai Lab Ltd.'s board of directors as of June 11, 2024.
Who has been appointed as the new Chairman of the Board at Zai Lab Ltd.?
Dr. Ge Li has been appointed as the new Chairman of the Board at Zai Lab Ltd.
Who are the newly elected directors at Zai Lab Ltd.?
Ms. Jian (Jane) Huang and Mr. Jonathan M. Wang have been elected as new directors at Zai Lab Ltd.
What other information is disclosed in this 8-K filing?
The filing also discloses compensatory arrangements of certain officers and includes Regulation FD disclosures and financial statements/exhibits.
What is Zai Lab Ltd.'s jurisdiction of incorporation and fiscal year end?
Zai Lab Ltd. is incorporated in the Cayman Islands and its fiscal year ends on December 31.
Filing Stats: 651 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-06-11 16:10:11
Key Financial Figures
- $0.000006 — resenting 10 Ordinary Shares, par value $0.000006 per share ZLAB The Nasdaq Global Market
Filing Documents
- zlab-20240611.htm (8-K) — 32KB
- a2024-6x10xharaldsretiremea.htm (EX-99.1) — 12KB
- image_0.jpg (GRAPHIC) — 31KB
- zailablogo.jpg (GRAPHIC) — 14KB
- 0001628280-24-027668.txt ( ) — 267KB
- zlab-20240611.xsd (EX-101.SCH) — 2KB
- zlab-20240611_def.xml (EX-101.DEF) — 16KB
- zlab-20240611_lab.xml (EX-101.LAB) — 27KB
- zlab-20240611_pre.xml (EX-101.PRE) — 16KB
- zlab-20240611_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On June 11, 2024, the Company also announced that Dr. Rafael Amado, President, Head of Global Oncology Research and Development, will be expanding his role to President, Head of Global Research and Development, effective upon Dr. Reinhart's retirement on June 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Zai Lab Limited on Ju ne 1 1 , 202 4 104 The cover page of this Current Report on Form 8-K is formatted in Inline XBRL
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZAI LAB LIMITED By: /s/ F. Ty Edmondson F. Ty Edmondson Chief Legal Officer and Corporate Secretary Date: June 11, 2024